Safety and Assessment of Breakthrough Therapies
- Identifying Infusion-related reactions to monoclonal antibodies in early phase clinical studies can help guide administration and pre-medication strategies   
February 14, 2018
BY: Russell Garland
- Tests that mimic real-world conditions are better than standard models in showing how chemicals react to soil, water and air. Our ongoing series, Chemical Attractions.
February 8, 2018
BY: Mary Parker
- The regulatory waters for biopesticide candidates can be choppy. Here are some expert tips that may ease the journey.
January 24, 2018
BY: Marloes Busschers
- Delving into how pharmaceuticals may adversely affect coagulation. A Charles River sabbatical story.
January 17, 2018
BY: Mary Parker
- How drug discovery and safety assessment are working in tandem to bring cellular therapies to market faster
January 4, 2018
BY: David Harris
- Cross-collaborations within companies can drive innovation in drug discovery and development. What's Hot in 2018.
December 18, 2017
BY: Ulrike Herbrand
- When we introduce a new therapy—whether it’s a re-engineered mosquito, a biologic or a synthetic drug—we have to think about the immediate and long-term implications of the intervention
December 11, 2017
BY: Alan Hoberman
- The FDA’s actions address the promise of innovative products and mounting concerns over stem cell clinics
November 22, 2017
BY: Shawna Jackman
- No substitute for human brain, but robots bring the brawn
October 16, 2017
BY: Mary Parker
- Using transgenic mice, Charles River scientists have traced a path that leads from inhaled styrene to cancer - a path that does not exist in humans.
October 10, 2017
BY: Mary Parker